Agessandro Abrahao
Co-Applicant
Assistant Professor of Medicine (Neurology) at University of Toronto | Staff Neurologist at Sunnybrook Health Sciences Centre
Associate Scientist at Sunnybrook Health Sciences Centre
NMD4C Involvement: Pillar 2: Clinical Research, Pillar 3: Clinical Practice Research
Email AgessandroResearch Interests: ALS, clinical trials, drug development, Neurophysiological biomarkers, MR-guided focused ultrasound for neurological diseases
Academic web profileGoogle Scholar profile
ResearchGate profile
Biography
Agessandro Abrahao, MD, is an academic neurologist with MSc degree in Neuroscience from the Federal University of Sao Paulo, Brazil and in Clinical Epidemiology from the Institute of Health Policy, Management and Evaluation, University of Toronto. He completed an advanced fellowship training in ALS/ Neuromuscular Diseases at Sunnybrook Health Sciences Centre – University of Toronto and is certified in EMG techniques by the Canadian Society of Clinical Neurophysiologists. Agessandro also served as the inaugural Sunnybrook Neuromodulation/Focused Ultrasound Fellow.
Agessandro’s research aims to accelerate the drug development and clinical trials for ALS. His research interests also include clinical trials and epidemiological studies in ALS and other neuromuscular disorders. He is also interested in the development of biomarkers for motor neuron function using transcranial magnetic stimulation and motor unit count techniques.
Recent Publications
Gopinath, G, Scantlebury, N, Sewell, IJ, Rohringer, CR, Sivadas, S, McSweeney, M et al.. Changes in Caregiver Burden Following Unilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor. Mov Disord Clin Pract. 2024. PMID:38576099
Scantlebury, N, Rabin, JS, De Schlichting, E, Hamani, C, Schwartz, ML, Lipsman, N et al.. Reply: Evaluating the Scope and Safety of Bilateral MRgFUS Thalamotomy for Essential Tremor: A Critical Analysis. Mov Disord Clin Pract. 2024.11 (3)320-321 PMID:38169118
Nestor, SM, Giacobbe, P, Abrahao, A, Davidson, B, Rabin, JS, Lipsman, N et al.. Advances in deep brain stimulation for the treatment of post-traumatic stress disorder. Expert Rev Med Devices. 2023.20 (12)995-998 PMID:37930275
Scantlebury, N, Rohringer, CR, Rabin, JS, Yunusova, Y, Huang, Y, Jones, RM et al.. Safety of Bilateral Staged Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor. Mov Disord Clin Pract. 2023.10 (10)1559-1561 PMID:37868927
Davidson, B, Scherer, M, Giacobbe, P, Nestor, S, Abrahao, A, Rabin, JS et al.. Mood biomarkers of response to deep brain stimulation in depression measured with a sensing system. Brain Stimul. 2023.16 (5)1371-1373 PMID:37696354
Sulistyo, A, Abrahao, A, Freitas, ME, Ritsma, B, Zinman, L. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2023.8 (8)CD004030 PMID:37579081
Bouvier, L, Green, JR, Tapia, CB, Tilton-Bolowsky, V, Maffei, MF, Fless, Z et al.. Amyotrophic Lateral Sclerosis-Bulbar Dysfunction Index-Remote: Test-Retest and Interrater Reliability of Candidate Items. Am J Speech Lang Pathol. 2023.32 (4S)1884-1900 PMID:37494887
Ozzoude, M, Varriano, B, Beaton, D, Ramirez, J, Adamo, S, Holmes, MF et al.. White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases. Alzheimers Res Ther. 2023.15 (1)114 PMID:37340319
Dilliott, AA, Berberian, SA, Sunderland, KM, Binns, MA, Zimmer, J, Ozzoude, M et al.. Rare neurovascular genetic and imaging markers across neurodegenerative diseases. Alzheimers Dement. 2023.19 (12)5583-5595 PMID:37272523
Rabin, JS, Gopinath, G, McSweeney, M, Scantlebury, N, Rohringer, CR, Sewell, IJ et al.. Patient satisfaction following unilateral MR-guided focused ultrasound for tremor: Who is satisfied and who is not?. Parkinsonism Relat Disord. 2023.112 105439 PMID:37263158
See more on PubMed